World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
63
Citations
15451
World Ranking
1802
National Ranking
902

Jeffrey D. Parvin publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Jeffrey D. Parvin sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 152 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Jeffrey D. Parvin D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey D. Parvin sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 63 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Jeffrey D. Parvin is affiliated with The Ohio State University in the United States. Their research focuses on key areas within biochemistry, genetics, and molecular biology, contributing extensively to topics related to DNA repair mechanisms, CRISPR and genetic engineering, as well as the role of BRCA gene mutations in cancer.

The scientist has published a significant body of work spanning molecular biology, genetics, oncology, immunology, and epidemiology. Their studies often explore cancer-related genetic mechanisms with a particular emphasis on DNA repair and PARP inhibition in cancer therapy.

Among their recent papers are:

  • Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells, 2021, PLoS ONE
  • The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays, 2022, The American Journal of Human Genetics
  • DNA repair function scores for 2172 variants in the BRCA1 amino-terminus, 2023, PLoS Genetics
  • Multiplexed assay of variant effect reveals residues of functional importance in the BRCA1 coiled-coil and serine cluster domains, 2023, PLoS ONE
  • Multiplexed functional analysis of TAP2 variants in regulating MHC-I cell surface abundance reveals overexpression of PLK1 downregulates antigen presentation, 2024, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors who have collaborated with Jeffrey D. Parvin include:

  • Gregory Nagy
  • Tapahsama Banerjee
  • S. Dhar
  • Aleksandra I. Adamovich
  • Mariame Diabate

The primary venues where their work has been published encompass:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS ONE
  • The American Journal of Human Genetics
  • PLoS Genetics
  • Cancer Research

Main fields of study in Jeffrey D. Parvin's research portfolio include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields covered are:

  • Molecular Biology
  • Genetics
  • Oncology
  • Immunology
  • Epidemiology

The central topics of their research involve:

  • DNA Repair Mechanisms
  • CRISPR and Genetic Engineering
  • BRCA gene mutations in cancer
  • PARP inhibition in cancer therapy
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction

Best Publications

  • Network modeling links breast cancer susceptibility and centrosome dysfunction.

    Miguel Angel Pujana;Jing Dong J Han;Lea M. Starita;Kristen N. Stevens

  • Amplification, expression, and packaging of a foreign gene by influenza virus

    Willem Luytjes;Mark Krystal;Masayoshi Enami;Jeffrey D. Parvin

  • RNA Helicase A Mediates Association of CBP with RNA Polymerase II

    Toshihiro Nakajima;Chiharu Uchida;Stephen F. Anderson;Chee-Gun Lee

  • BRCA1 is a component of the RNA polymerase II holoenzyme

    Ralph Scully;Stephen F. Anderson;David M. Chao;Wanjiang Wei

  • α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

    Eirene Kontopoulos;Jeffrey D. Parvin;Mel B. Feany

  • BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.

    Stephen F. Anderson;Brian P. Schlegel;Toshihiro Nakajima;Eric S. Wolpin

  • DNA topology and a minimal set of basal factors for transcription by RNA polymerase II.

    Jeffrey D. Parvin;Phillip A. Sharp

  • Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1.

    J D Parvin;A Moscona;W T Pan;J M Leider

  • Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle

    Ming-Ta Hsu;Jeffrey D. Parvin;Suresh Gupta;Mark Krystal

  • BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome Number

    Lea M. Starita;Yuka Machida;Satish Sankaran;Joshua E. Elias

  • Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase.

    Partha Saha;Junjie Chen;Kelly C. Thome;Stephanie J. Lawlis

  • Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene

    Deborah A. Buonagurio;Susumu Nakada;Jeffrey D. Parvin;Mark Krystal

  • Patterns and functional implications of rare germline variants across 12 cancer types

    Charles Lu;Mingchao Xie;Michael C. Wendl;Jiayin Wang;Jiayin Wang

  • A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II.

    Henri Marc Bourbon;Andres Aguilera;Aseem Z. Ansari;Francisco J. Asturias

  • Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

    Lea M. Starita;David L. Young;Muhtadi Islam;Jacob O. Kitzman

  • Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors.

    T Nakajima;C Uchida;S F Anderson;J D Parvin

  • The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair.

    Lea M Starita;Jeffrey D Parvin

  • Factors associated with the mammalian RNA polymerase II holoenzyme.

    Andrew S. Neish;Stephen F. Anderson;Brian P. Schlegel;Wanjiang Wei

  • Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor

    Jeffrey D. Parvin;Jeffrey D. Parvin;Richard J. McCormick;Phillip A. Sharp;David E. Fisher

  • Promoter analysis of influenza virus RNA polymerase.

    J D Parvin;P Palese;A Honda;A Ishihama

Frequent Co-Authors

Peter Palese
Peter Palese Icahn School of Medicine at Mount Sinai
Mark Krystal
Mark Krystal ViiV Healthcare (United Kingdom)
Stephen Anderson
Stephen Anderson Rutgers, The State University of New Jersey
Tim H M Huang
Tim H M Huang The University of Texas Health Science Center at San Antonio
Chikashi Ishioka
Chikashi Ishioka Tohoku University
Anindya Dutta
Anindya Dutta University of Alabama at Birmingham
Ümit V. Çatalyürek
Ümit V. Çatalyürek Georgia Institute of Technology
Stanley Fields
Stanley Fields University of Washington
Jay Shendure
Jay Shendure University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens a wide range of career opportunities and advanced degree options, especially in fields where science merges with healthcare. For those considering a shift to nursing or advancing their qualifications, several online pathways provide both flexibility and accelerated completion timelines.

Many molecular biology graduates explore how to become nurse practitioner to leverage their scientific background into direct patient care roles. Accelerated programs like the rn to bsn online and adn to np pathways are especially popular for those who already hold some nursing credentials and wish to advance quickly.

For individuals from a non-nursing background—such as molecular biology—options like the direct entry msn online provide a fast track into advanced nursing practice. These programs make it possible to transition careers and make a meaningful impact in the healthcare field, building on the strong scientific foundation gained in molecular biology studies.

Best Scientists Citing Jeffrey D. Parvin

Trending Scientists

Recently Published Articles